Fig. 1 · Structure
Documents & Downloads
Luvixasertib hydrochloride
Cat. No.
A55059
CAS
1610677-37-6
TTK/Mps1 Inhibitor
Luvixasertib hydrochloride is a highly selective inhibitor of TTK/Mps1, demonstrating an IC50 of 1.7 nM for TTK in vitro. This compound exhibits significant anti-cancer activity, making it a valuable tool for cancer research. Its mechanism of action targets crucial mitotic processes, providing insights into cell cycle regulation and tumorigenesis. Luvixasertib hydrochloride is suitable for studies focused on cancer biology and therapeutic development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1610677-37-6 |
| Applications | TTK/Mps1 Inhibitor |
| Formula | C28H31ClN6O3 |
| Molecular Weight | 535.04 |
| Synonyms | CFI-402257 hydrochloride |
| SMILES | CC1=CC(C2=C3N=C(OC4=CN=CC=C4)C=C(NC[C@@H]5C[C@@](O)(C)C5)N3N=C2)=CC=C1C(NC6CC6)=O.Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.